Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Effect of Propofol on Acid Reflux Measured with the Bravo pH Monitoring System.

Chawla A, Girda E, Walker G, Turcotte Benedict F, Tempel M, Morganstern J.

ISRN Gastroenterol. 2013 Apr 22;2013:605931. doi: 10.1155/2013/605931. Print 2013.

2.

24 Versus 48-hour bravo pH monitoring.

Chander B, Hanley-Williams N, Deng Y, Sheth A.

J Clin Gastroenterol. 2012 Mar;46(3):197-200. doi: 10.1097/MCG.0b013e31822f3c4f.

PMID:
21959323
3.

Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.

Ahlawat SK, Novak DJ, Williams DC, Maher KA, Barton F, Benjamin SB.

J Clin Gastroenterol. 2006 Jan;40(1):20-4.

PMID:
16340628
4.

Does deep sedation impact the results of 48 hours catheterless pH testing?

Korrapati V, Babich JP, Balani A, Grendell JH, Kongara KR.

World J Gastroenterol. 2011 Mar 14;17(10):1304-7. doi: 10.3748/wjg.v17.i10.1304.

5.

Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.

López-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macías M, Silny J, Sifrim D.

Pediatrics. 2006 Aug;118(2):e299-308. Epub 2006 Jul 10.

PMID:
16831894
6.

[Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].

Mönkemüller K, Neumann H, Fry LC, Kolfenbach S, Malfertheiner P.

Z Gastroenterol. 2009 Apr;47(4):351-6. doi: 10.1055/s-2008-1027945. Epub 2009 Apr 8. German.

PMID:
19358061
7.

Effect of anesthesia on gastroesophageal reflux in children: a study using BRAVO wireless pH study measurements.

Rodriguez L, Morley-Fletcher A, Souza A, Rosengaus L, Nurko S.

Neurogastroenterol Motil. 2015 Nov;27(11):1553-8. doi: 10.1111/nmo.12652. Epub 2015 Aug 12.

8.

Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?

Bechtold ML, Holly JS, Thaler K, Marshall JB.

World J Gastroenterol. 2007 Aug 14;13(30):4091-5.

9.

Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System.

Lawenko RM, Lee YY.

J Neurogastroenterol Motil. 2016 Jan 31;22(1):25-30. doi: 10.5056/jnm15151.

10.

Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.

Ayazi S, Hagen JA, Zehetner J, Banki F, Augustin F, Ayazi A, DeMeester SR, Oh DS, Sohn HJ, Lipham JC, DeMeester TR.

Surg Endosc. 2011 Jul;25(7):2219-23. doi: 10.1007/s00464-010-1529-5. Epub 2011 Feb 27.

11.

Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.

Cabrera J, Davis M, Horn D, Pfefferkorn M, Croffie JM.

J Pediatr Gastroenterol Nutr. 2011 Oct;53(4):404-8. doi: 10.1097/MPG.0b013e3182203caa.

PMID:
21519281
12.

48-hour wireless oesophageal pH-monitoring in children: are two days better than one?

Gunnarsdóttir A, Stenström P, Arnbjörnsson E.

Eur J Pediatr Surg. 2007 Dec;17(6):378-81.

PMID:
18072019
14.

Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy.

Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA, Demeester TR.

Clin Gastroenterol Hepatol. 2009 Jan;7(1):60-7. doi: 10.1016/j.cgh.2008.08.020. Epub 2008 Aug 16.

PMID:
18976965
15.

Oesophageal pH monitoring using the Bravo catheter-free radio capsule.

Gillies RS, Stratford JM, Booth MI, Dehn TC.

Eur J Gastroenterol Hepatol. 2007 Jan;19(1):57-63.

PMID:
17206078
16.

Bravo 48-hour Wireless pH Monitoring in Patients With Non-cardiac Chest Pain. Objective Gastroesophageal Reflux Disease Parameters Predict the Responses to Proton Pump Inhibitors.

Karamanolis G, Triantafyllou K, Psatha P, Vlachogiannakos I, Gaglia A, Polymeros D, Fessatou S, Triantafyllou M, Papanikolaou IS, Ladas SD.

J Neurogastroenterol Motil. 2012 Apr;18(2):169-73. doi: 10.5056/jnm.2012.18.2.169. Epub 2012 Apr 9.

17.

[Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].

Valdovinos Díaz MA, Remes Troche JM, Ruiz Aguilar JC, Schmulson MJ, Valdovinos-Andraca F.

Rev Gastroenterol Mex. 2004 Apr-Jun;69(2):62-8. Spanish.

PMID:
15757153
18.

To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort.

Ang D, Teo EK, Ang TL, Ong J, Poh CH, Tan J, Fock KM.

J Dig Dis. 2010 Feb;11(1):19-27. doi: 10.1111/j.1751-2980.2009.00409.x.

PMID:
20132427
19.

Continuous 48-Hour Wireless Esophageal pH Monitoring in Children: Comparison Between Days 1 and 2.

Ravi A, Gunasekaran T, Berman J.

J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):87-9. doi: 10.1097/MPG.0000000000000908.

PMID:
26196198
20.

Tolerability and clinical utility of the Bravo pH capsule in children.

Lacy BE, Edwards S, Paquette L, Weiss J, Kelley ML Jr, Ornvold K.

J Clin Gastroenterol. 2009 Jul;43(6):514-9. doi: 10.1097/MCG.0b013e31818fba38.

PMID:
19349903

Supplemental Content

Support Center